Mesonephric-like Adenocarcinoma of the Female Genital Tract: A Comprehensive Review of Clinicopathological,Immunophenotypic,Molecular Features,and Clinical Management
Restricted accessReview articleFirst published online 2026
Mesonephric-like Adenocarcinoma of the Female Genital Tract: A Comprehensive Review of Clinicopathological,Immunophenotypic,Molecular Features,and Clinical Management
Mesonephric adenocarcinoma (MA) is a non-HPV associated tumor originating from mesonephric remnants, predominantly occurring in the uterine cervix. Mesonephric-like adenocarcinoma (MLA) is a recently recognized rare malignancy of the female genital tract. Its histomorphology, immunohistochemistry, and molecular characteristics are similar to those of MA. However, unlike MA, MLA is not associated with mesonephric remnants.
Summary:
Histologically, MLA can present various patterns including tubule-like, glandular, papillary, solid, sex cord-like, trabecular, retiform, cribriform, glomeruloid, and spindle cell patterns. Immunohistochemically, most MLAs show negative or focal weak positive expression for ER, while being positive for TTF-1, CD10, and GATA3. Molecularly, these tumors often harbor KRAS gene mutations. This article summarizes the research progress on MLA, aiming to enhance the understanding of this tumor type among clinicians and pathologists.
MirkovicJMcFarlandMGarciaE, et al.Targeted genomic profiling reveals recurrent KRAS mutations in mesonephric-like adenocarcinomas of the female genital tract. Am J Surg Pathol. 2018;42(2):227-233. doi:10.1097/PAS.0000000000000958
2.
KandothCSchultzNCherniackAD, et al.Integrated genomic characterization of endometrial carcinoma. Nature. 2013;497(7447):67-73. doi:10.1038/nature12113
3.
GibbardECochraneDRPorsJ, et al.Whole-proteome analysis of mesonephric-derived cancers describes new potential biomarkers. Human Pathol. 2020;108:1-11. doi:10.1016/j.humpath.2020.10.005
4.
EuscherEDBassettRDuoseDY, et al.Mesonephric-like carcinoma of the endometrium: a subset of endometrial carcinoma with an aggressive behavior. Am J Surg Pathol. 2020;44(4):429-443. doi:10.1097/PAS.0000000000001401
5.
KolinDLCostiganDCDongF, et al.A combined morphologic and molecular approach to retrospectively identify KRAS-mutated mesonephric-like adenocarcinomas of the endometrium. Am J Surg Pathol. 2019;43(3):389-398. doi:10.1097/PAS.0000000000001193
6.
NaKKimHS. Clinicopathologic and molecular characteristics of mesonephric adenocarcinoma arising from the uterine body. Am J Surg Pathol. 2019;43(1):12-25. doi:10.1097/PAS.0000000000000991
7.
WHO. Classification of Tumours Editorial Board. WHO Classification of Tumours: Female Genital Tumours. 5th ed. Volume 4. WHO; 2020.
8.
KimHGKimHYeoMY, et al.Mesonephric-like adenocarcinoma of the Uterine Corpus: comprehensive analyses of clinicopathological, molecular, and prognostic characteristics with retrospective review of 237 endometrial carcinoma cases. Cancer Genomics Proteomics. 2022;19(4):526-539. doi:10.21873/cgp.20338
9.
SeayKAkanbiTBustamanteB, et al.Mesonephric-like adenocarcinoma of the ovary with co-existent endometriosis: a case report and review of the literature. Gynecol Oncol Rep. 2020;34:100657. doi:10.1016/j.gore.2020.100657. eCollection 2020 Nov.
10.
ChapelDBJosephNMKrauszT, et al.An ovarian adenocarcinoma with combined low-grade serous and mesonephric morphologies suggests a Mullerian origin for some mesonephric carcinomas. Int J Gynecol Pathol. 2018;37:448-459. doi:10.1097/PGP.0000000000000444
11.
YanoMShintaniDKatohT, et al.Coexistence of endometrial mesonephric-like adenocarcinoma and endometrioid carcinoma suggests a Müllerian duct lineage: a case report. Diagn Pathol. 2019;14(1):54. doi:10.1186/s13000-019-0830-4
12.
McFarlandMQuickCMMcCluggageWG. Hormone receptor-negative, thyroid transcription factor 1-positive uterine and ovarian adenocarcinomas: report of a series of mesonephric-like adenocarcinomas. Histopathology. 2016;68(7):1013-1120. doi:10.1111/his.12895
13.
BaguéSRodríguezIMPratJ. Malignant mesonephric tumors of the female genital tract: a clinicopathologic study of 9 cases. Am J Surg Pathol. 2004;28(5):601-607. doi:10.1097/00000478-200405000-00006
14.
MirkovicJOlkhov-MitselEAmemiyaY, et al.Mesonephric-like adenocarcinoma of the female genital tract: novel observations and detailed molecular characterisation of mixed tumours and mesonephric-like carcinosarcomas. Histopathology. 2023;82(7):978-990. doi:10.1111/his.14892
15.
DundrPGregováMNěmejcováK, et al.Ovarian mesonephric-like adenocarcinoma arising in serous borderline tumor: a case report with complex morphological and molecular analysis. Diag Pathol. 2020;15(1):91. doi:10.1186/s13000-020-01012-z
16.
McCluggageWGVosmikovaHLacoJ, et al.Ovarian combined low-grade serous and mesonephric-like adenocarcinoma: further evidence for a Mullerian origin of mesonephric-like adenocarcinoma. Int J Gynecol Pathol. 2020;39(1):84-92. doi:10.1097/PGP.0000000000000573
17.
MillsAMEuscherEDMcCluggageWG, et al.Mesonephric-like adenocarcinoma (MLA) diagnostic criteria and controversies: perspectives and guidance from pathologists in the MLA consortium. Int J Gynecol Pathol. 2026 Jan 1;45(1):57-78. doi:10.1097/PGP.0000000000001150
18.
RingKLMillsAMHowittBE, et al.Mesonephric-like adenocarcinoma of the female genital tract: pathologic diagnosis, clinical outcomes, and novel therapeutics. Gynecol Oncol. 2025 Jun;197:57-65. doi:10.1016/j.ygyno.2025.04.583
19.
PraissAParkKMakkerS, et al.Controversies in the management of mesonephric and mesonephric-like adenocarcinomas of the female genital tract. Int J Gynecol Cancer. 2025 Mar;35(3):101638. doi:10.1016/j.ijgc.2025.101638
20.
YanSTianYLiM, et al.Endometrial mesonephric-like adenocarcinoma: clinicopathologic features, treatment, and outcomes. Biomol Biomed. 2025 Nov 5;26(4):668-678. doi:10.17305/bb.2025.12993
21.
KohH-HParkEKimH-S. Mesonephric-like adenocarcinoma of the uterine corpus: genomic and immunohistochemical profiling with comprehensive clinicopathological analysis of 17 consecutive cases from a single institution. Biomedicines. 2023 Aug 15;11(8):2269. doi:10.3390/biomedicines11082269
22.
PorsJSeguraSChiuDS, et al.Clinicopathologic characteristics of mesonephric adenocarcinomas and mesonephric-like adenocarcinomas in the gynecologic tract: a multi-institutional study. Am J Surg Pathol. 2021;45(4):498-506. doi:10.1097/PAS.0000000000001612
23.
TahirMXingDDingQ, et al.Identifying mesonephric-like adenocarcinoma of the endometrium by combining SOX17 and PAX8 immunohistochemistry. Histopathology. 2025 Jan;86(2):268-277. doi:10.1111/his.15312. Epub 2024 Sep 4.
24.
da SilvaEMFixDJSebastiaoAPM, et al.Mesonephric and mesonephric-like carcinomas of the female genital tract: molecular characterization including cases with mixed histology and matched metastases. Mod Pathol. 2021;34(8):1570-1587. doi:10.1038/s41379-021-00799-6
25.
BrambsCEHornL-CHillerR, et al.Mesonephric-like adenocarcinoma of the female genital tract: possible role of KRAS-targeted treatment—detailed molecular analysis of a case series and review of the literature for targetable somatic KRAS-mutations. J Cancer Res Clin Oncol. 2023;149(17):15727-15736. doi:10.1007/s00432-023-05306-9. Epub 2023 Sep 5.
26.
KommossFKLeeC-HTessier-CloutierB, et al.Mesonephric-like adenocarcinoma harbours characteristic copy number variations and a distinct DNA methylation signature closely related to mesonephric adenocarcinoma of the cervix. J Pathol. 2024;262(1):4-9. doi:10.1002/path.6217. Epub 2023 Oct 18.
27.
ShalabyAShenoyV. Female adnexal tumor of probable wolffian origin: a review. Arch Pathol Lab Med. 2022;146(2):166-171. doi:10.5858/arpa.2020-0432-OA
28.
HornLCHöhnAKKrückenI, et al.Mesonephric-Like adenocarcinomas of the uterine corpus: report of a case series and review of the literature indicating poor prognosis for this subtype of endometrial adenocarcinoma. J Cancer Res Clin Oncol. 2020;146(4):971-983. doi:10.1007/s00432-019-03123-7
29.
MaTChaiMShouH, et al.Mesonephric-like adenocarcinoma of uterine corpus: a clinicopathological and targeted genomic profiling study in a single institution. Front Oncol. 2022;12:911695. doi:10.3389/fonc.2022.911695. eCollection 2022.
30.
MillsAMJenkinsTMHowittBE, et al.Mesonephric-like endometrial carcinoma: results from immunohistochemical screening of 300 endometrial carcinomas and carcinosarcomas for this often overlooked and potentially aggressive entity. Am J Surg Pathol. 2022;46(7):921-932. doi:10.1097/PAS.0000000000001873. Epub 2022 Feb 24.
